revefenacin

FDA Drug Profile — YUPELRI

revefenacin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including YUPELRI. Available dosage form: solution.

Drug Details

Generic Name
revefenacin
Brand Names
YUPELRI
Application Number
NDA210598
Sponsor
Viatris Specialty LLC
NDC Codes
1
Dosage Forms
SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients
REVEFENACIN

Indications and Usage

1 INDICATIONS AND USAGE YUPELRI is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) .